Latest Articlesddd
Moderna Inc: A Public Offering Moderna (MRNA) announced the pricing of an underwritten public offering of …
Moderna Postive News for mRNA-1273 Vaccine Against Novel Coronavirus (COVID-19) Moderna (MRNA) announced positive interim clinical …
Sorrento Therapeutics Anti-SARS-CoV-2 Antibody STI-1499 Sorrento Therapeutics (SRNE) announced that its anti-SARS-CoV-2 antibody, STI-1499, demonstrated 100% …
Bristol-Myers Squibb and bluebird bio Bristol-Myers Squibb (BMY) and bluebird bio (
Novavax Still Rallying After Grant The Grant That Continues To Rally the Stock Novavax (NVAX) stock …
Impacting News from Novavax, CymaBay Therapeutics and Sanofi SA Novavax The Grant That Rallied the Stock …
Prohost Letter #440 Coronavirus The Therapeutics Gilead’s Remdesivir Treating COVID-19 patients requires therapeutic products that can …
Pluristem Therapeutics IND Cleared by FDA for PLX Cells in COVID-19 Treatment From Pluristem Therapeutics (PSTI) …
Moderna Coronavirus Vaccine Cleared for Phase 2 Moderna (MRNA) provided business updates for the first quarter of …
Alexion to Acquire Portola Alexion (ALXN) and Portola (PTLA) entered into a definitive merger agreement and …
Applied DNA Sciences and Takis Biotech Announce the Production of Neutralizing Antibodies Against SARS-CoV-2 After DNA …
CytomX Therapeutics CytomX (CTMX) is a clinical-stage oncology-focused biopharmaceutical company developing a novel class of investigational …
Moderna Submitted an IND for Its mRNA Vaccine Candidate for Novel Coronavirus Moderna (MRNA) announced that …
Sanofi and Regeneron: Results from Libtayo® Trial Sanofi (SNY) and Regeneron (REGN)
Theravance Biopharma: Near-Term Game-Changing PDUFAS Some of the Prohost Portfolio selected companies are having near term …
Halozyme and PTC Therapeutics: Near-Term Game-Changing PDUFAS Some of the Prohost Portfolio selected companies are having …
Compugen: In the NEWS Compugen (CGEN) was granted a new patent for the composition of COM701 …
The Week in Review #50 The World FOCUS is COVID-19 The world FOCUS right now is …
Exelixis Rallying from CheckMate-9ER Trial Results Exelixis (EXEL) and Bristol-Myers Squibb (
Gilead Sciences Gilead (GILD) stock soared after market hours adding $11 to the $1.90 the stock …
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Accept Privacy policy
